市場調查報告書
商品編碼
922030

全球創傷清創手術市場:成長,趨勢,及預測

Wound Debridement Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球創傷清創手術市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各產品·手法·創傷類型·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 糖尿病及相關創傷的發生率上升
    • 外科手術數量的增加
    • 老年人口的增加
  • 市場阻礙因素
    • 治療費用高
  • 波特的五力分析

第5章 市場區隔

  • 各產品
    • 凝膠
    • 軟膏·乳霜
    • 手術器具
    • 超音波設備
    • 機械清創手術墊片
    • 其他
  • 各手法
    • 外科
    • 酵素
    • 機器
    • 自我融化
    • 其他
  • 各創傷類型
    • 慢性潰瘍
    • 手術·外傷
    • 燙傷
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Arobella Medical
    • B. Braun Melsungen AG
    • DeRoyal Industries
    • Histologics, LLC
    • Lohmann & Rauscher
    • Medaxis LLC
    • Misonix, Inc.
    • Monarch Labs
    • PulseCare Medical
    • Sanara MedTech Inc.
    • Smith & Nephew plc

第7章 市場機會及今後趨勢

目錄
Product Code: 67239

Factors such as rising incidence of diabetes & associated wounds, an increase in the volume of surgical procedures and growing geriatric population are driving the growth of the wound debridement market. The incidence of diabetes among all ages is increasing, mainly due to obesity, unhealthy diet, and physical inactivity. The incidence of chronic wounds, especially foot ulcers is increasing among the diabetic population resulting in the increased usage of wound debridement products. Therefore, the growing focus toward the development of better treatment options, along with huge burden of diseases is expected to drive the wound debridement market. However, the high treatment cost is expected to restrain the growth of the global market in the forecast period.

Key Market Trends

Gels Segment is Expected to Dominate the Market in the Forecast Years

Based on products, the market is segmented into gels, ointments & creams, surgical devices, Ultrasound devices, mechanical debridement pads, and other wound debridement products. Gels segment is expected to dominate the market as it maintains a moist wound environment and had certain benefits as compared to other products such as no inflammation, less bleeding, and removal of necrotic tissues safely, without causing infection. These are recommended for wounds that range from dry to mildly exudating as one of the important barriers to wound healing is the removal of necrotic tissue from the wound bed. In addition, increase in volume of surgical procedures and rising diabetic population also contributes to the growth of wound debridement market.

North America leads the Wound Debridement Market

North America leads the wound debridement market owing to growing geriatric and diabetic populations, followed by Europe. However, Asia Pacific is expected to grow at a faster rate due to the increasing awareness regarding advanced treatment options, rising incidence of chronic wounds and the presence of emerging economies in this region.

Competitive Landscape

The Wound Debridement market is competitive and many of the global players are into the market. For instance - Arobella Medical, B. Braun Melsungen AG, DeRoyal Industries, Histologics LLC, Lohmann & Rauscher, Medaxis AG, Misonix, Inc., Smith & Nephew plc etc. are providing these products across the globe.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Diabetes and Associated Wounds
    • 4.2.2 Increase in Volume of Surgical Procedures
    • 4.2.3 Growing Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 High Treatment Cost
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Gels
    • 5.1.2 Ointments & Creams
    • 5.1.3 Surgical Devices
    • 5.1.4 Ultrasound Devices
    • 5.1.5 Mechanical Debridement Pads
    • 5.1.6 Other Wound Debridement Products
  • 5.2 By Method
    • 5.2.1 Surgical Method
    • 5.2.2 Enzymatic Method
    • 5.2.3 Mechanical Method
    • 5.2.4 Autolytic Method
    • 5.2.5 Others
  • 5.3 By Wound Type
    • 5.3.1 Chronic Ulcers
    • 5.3.2 Surgical & Traumatic Wounds
    • 5.3.3 Burns
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Arobella Medical
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 DeRoyal Industries
    • 6.1.4 Histologics, LLC
    • 6.1.5 Lohmann & Rauscher
    • 6.1.6 Medaxis LLC
    • 6.1.7 Misonix, Inc.
    • 6.1.8 Monarch Labs
    • 6.1.9 PulseCare Medical
    • 6.1.10 Smith & Nephew plc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS